SC 13G/A: Terns Pharmaceuticals, Inc.
Ticker: TERN · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 1831363
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Terns Pharmaceuticals, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,832 words · 7 min read · ~6 pages · Grade level 7.8 · Accepted 2024-02-13 17:21:57
Key Financial Figures
- $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
Filing Documents
- ea193270-13ga3lavbio5_terns.htm (SC 13G/A) — 158KB
- ea193270ex99-1_terns.htm (EX-99.1) — 12KB
- 0001213900-24-013443.txt ( ) — 171KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2024 Hopewell Resources Holdings Limited By: /s/ Yi Shi Name: Yi Shi Title: Managing Partner Dated: February 13, 2024 Oriental Spring Venture Limited By: /s/ Yi Shi Name: Yi Shi Title: Managing Partner Dated: February 13, 2024 LAV Aqua Limited By: /s/ Yi Shi Name: Yi Shi Title: Managing Partner Dated: February 13, 2024 LAV Biosciences Fund V, L.P. By: /s/ Yi Shi Name: Yi Shi Title: Managing Partner Dated: February 13, 2024 Yi Shi By: /s/ Yi Shi Name: Yi Shi CUSIP No. 880881107 Page 10 of 10 EXHIBIT INDEX Exhibit Found on Sequentially Numbered Page Exhibit 99.1: Agreement of Joint Filing